Syncom Formulations Board Meeting Scheduled for 13th Nov'26 to Consider Q2 Results
Syncom Formulations India Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Syncom Formulations Board Meeting Scheduled for 13th Nov'26 to Consider Q2 Results Syncom Formulations (India) Limited has scheduled its Board of Directors meeting for 13th Nov'26. The board will consider and approve the standalone and consolidated unaudited financial results, along with the limited review report by auditors, for the quarter and half-year ended 30th Sep'26. Additionally, the board will review and approve the unaudited statements of assets and liabilities as well as cash flows for the half-year period.
Original exchange filing (PDF)
More announcements from Syncom Formulations India Ltd
- Syncom Formulations (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Submission of standalone & Consolidated Unaudited Financial Results along with limited review report, statement of assets and liabilities and cash flow statements for the Quarter and Half .... 路 13 Nov 2026
- Pursuant to Regulation 33(3) of SEBI (LODR) Regulations, 2015, we are pleased to submit herewith the following: 1. Standalone and Consolidated Un-Audited Financial Results of the Company .... 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 13 Nov 2026
- SYNCOM FORMULATIONS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 13 Nov 2026
- Corporate Announcement regarding approval and payment of final dividend. 路 02 Oct 2026
- Disclosure under reg 30 of SEBI (LODR) reg 2015 read with sub clause 7 of para A of part A of schedule /// change in directorate. 路 02 Oct 2026
- Outcome of 38th AGM 路 02 Oct 2026
